Skip to main content
. 1998 Aug 18;95(17):10100–10105. doi: 10.1073/pnas.95.17.10100

Table 1.

CNS pathology of mice treated with GGF2 via the s.c. or i.v. route

Treatment Pathology Clinical score*
8 dpt 19 dpt 42 dpt
Vehicle Inflamm. 3.4* 2.5 2.3
Demyel. 2.6 2.6 1.9
2.0 mg GGF2 s.c. Inflamm. 1.1 2.2 1.8
Demyel. 0.4 1.6 0.7
2 mg GGF2 i.v. Inflamm. 2.2 2.4
Demyel. 1.0 1.7
1 mg GGF2 i.v. Inflamm. 3.0 2.3 2.4
Demyel. 2.2 1.9 2.2
*

Animals scored on scale of 0–5. Each score represents the mean of 18 slides per animal from 9 levels of the neuraxis. 

No survivors in this i.v. group. Lower dosing via the i.v. route and s.c. administration at all dose levels tested did not result in any deaths.